Skip to main content

Use the controls below to filter resources by category, search for words or phrases, or filter by multiple attributes including category, format, author and more.

Newest Resources


Operational Assessment: Administration and Management of Sayana® Press in Clinics and Communities in Uganda

This operational assessment in Uganda examines the extent to which DMPA-SC (brand name Sayana® Press) facilitates the logistics of managing and administering injectable contraception and assesses whether providers in Uganda find benefits in this new presentation.

Institutional Author(s): PATH
Publication date: May, 2013

Brief Operational Assessment: Administration and Management of Sayana® Press in Clinics and Communities in Uganda

Key Indicators for Community-based Access to Injectable Contraception Pilot Studies

An indicator is a measure of program performance that is tracked over time. This document presents potential process and outcome indicators organized according to phase of the community-based access to injectables (CBA2I) pilot along with the related evaluation questions, data sources and measurement tools. The list can be adapted to local context and program goals to assess a pilot’s progress toward intended outputs and achievement of goals.

Institutional Author(s): FHI 360
Publication date: 2011

Logistics and Waste Management Benefits of depo-subQ in Uniject

This four-page brief describes results from three analyses conducted by PATH and John Snow Inc. (JSI) comparing the intramuscular version of depot medroxyprogesterone acetate (DMPA) injectable contraceptive compared with the new DMPA-SC formulation packaged in the Uniject injection system. The analyses focused on waste management implications and identified key quantitative and qualitative differences between the two products.

Institutional Author(s): PATH, JSI, Inc.
Publication date: February, 2011

Access to Medicines and Drug Regulation in Developing Countries: a Resource Guide for DFID

This 16-page paper provides an overview of the debate about how developing country drug regulation agencies are funded and the extent to which they should build local capacity or rely on regulators in developed countries.

Institutional Author(s): DFID Health Systems Resource Centre
Publication date: January, 2004

Report Web page